Close

Tag: Vaccination

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351,...

Moderna Commercial Expansion Accelerates Vaccine Launches

Moderna is strengthening its commercial leadership and operational structure as it prepares for a series of anticipated vaccine launches over the next several years....

SK Bioscience Inks Colombia Vaccine Localization Deal

In a critical step for Colombia vaccine localization, SK Bioscience will execute a vaccine technology transfer with Colombia’s state-owned pharmaceutical enterprise, VECOL. The partnership...

Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy

After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which...

Largest Vaccine Manufacturing Facility in Egypt Launched

Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the...

Onshoring of Drug Product Manufacturing to Massachusetts

Moderna is set to expand its US manufacturing capabilities through the onshoring of drug product manufacturing to its present Moderna Technology Center - MTC located...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »